According to Acumen Research and Consulting, the global Joint Pain Injections market is expected to grow at noteworthy CAGR around 8 % throughout the forecast period and reach around US$ 5.7 billion by 2026. The report provides analysis of global Joint Pain Injections market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.
Included in the projected period are expected to boost common pain injections market, increased prevalence and incidents of joint disorder, high unmet requirements in joint pain pain patients, an enhanced geriatric population and increased acceptance for relatively new treatment options in developing countries. According to a WHO paper, more then 150 diseases and syndromes, usually progressive and associated with pain, consist of the musculoskeletal conditions. The most socially affected conditions include rheumatoid arthritis, osteoarthritis, backbone disorders and serious limb-trauma.
Arthritis is the leading cause of disability among adults in the U.S., according to facts published by the Arthritis Foundation. About 54 million adults and 300,000 babies and children in the United States are affected by arthritis or rheumatic diseases. In the United States, more than 78 million people are likely to experience arthritis diagnosed by the doctor by 2040. Osteoarthritis is also the most frequent type of arthritis and affects around 31 million people in the United States. Increased Arthritis prevalence further boosts requirements for disease-modifying treatments, which are projected to boost joint pain injections in the forecast period.
Based on injection type, joint type, end user and region, the global injection pain market was separated. With regard to injection type, corticosteroid and, hyaluronic acid injections, and others have all been classified on the global market. The segment of hyaluronic acid injections dominates the value of the joint pain injection market. The segment is likely to be driven by increased acceptance of hyaluronic acid injections as an alternative to knee surgery. The segment of corticosteroids is also expected to expand over the forecast period in a significant CAGR. According to NCBI, intra-articular corticosteroid injections are more effective in short-term pain relief for assessment of the efficacy of corticosteroid injections.
With regard to articulation, the world market in ankle and knee, hip joint, shoulder and elbow, spinal facet joints and other parts was classified. The segment of the knee and ankle dominates the value market for joint pain injections. This is mainly due to the increased incidence and prevalence of knee-related conditions throughout the world. In a substantial CAGR over time, the shoulder-to-cole segment is expected to expand. It is due to the widespread occurrence of shoulder pain due to the increased use among the general populace of gadgets like mobile phones, PCs and laptops.
The joint pain injections market is divided in hospital pharmacies, retail pharmacies and online pharmacies with regard to distribution channels. The hospital pharmaceutical segment held a significant market share and in 2018 it was followed by the retail sector. Due to increasing preference for joint pain treatment hospitals requiring skilled staff for parenteral administration, its market share is expected to remain ongoing during the forecast period. During the forecast period, the retail pharmacies segment is expected to expand significantly in CAGR. The high growth rate is due to the high preference for the Latin America and the Middle East & Africa distribution channel.
In terms of region, the joint pain injections market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global joint pain injections market, The increased prevalence of joint-related disturbance, technological development, an increase in the number of geriatrists and a strong prevalence of obesities and expenditure on health in the region are due to high acceptance of viscosupplementation. Due to increased awareness of joint pain in developing countries, such as Indian and geriatric growth and high acceptance of viscombining in Japan, the market is expected to expand in Asia-Pacific during the forecasted period at considerably high CAGR. Due to the increased consciousness over joint pain, such as India, the growth of geriatric populations and the high reception of viscosupplementation in Japan, the market in Asia Pacific will be expanding at a considerable level during the projected period.
Global Joint Pain Injections Market, by Type
Global Joint Pain Injections Market, by Joint Type
Global Joint Pain Injections Market, by Distribution Channel
Global Joint Pain Injections Market, by Geography
The market research study on “Joint Pain Injections Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Joint Pain Injections market segments with market dynamics and their impact. The report also covers basic technology development policies.
ARC, which delivers global business information reports and services, is a global market intelligence company. Thousands of decision-makers are inspired by our exclusive mix of quantitative forecasting and trend analyses. Our experienced team of experts in the field of data collection, research and consulting uses proprietary data sources and various tools and techniques.
Our data repository is constantly updated and revised in order to always reflect the latest trends and information by a team of research experts. ARC uses rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports through its broad research and analysis capabilities.
In this study, the leading global and regional market competitours, which includes key strategic market evolutions, includes R&D, the launch of new products, M&A, contracts, collaborations, partnerships, joint ventures and regional growth. The study assessed the key market aspects, including revenue, prices, capacity, rate of use of capacity, gross, manufacture, production, consumption, import / export, supply / demand, cost, market share, CAGR and gross margin. The study offers, in addition to relevant segments of the market and subsegments, an extensive analysis of the key market dynamics and their new trends. The Global Rebar Processing Equipment Market Report includes the data of the major players of the sector and their market scope with a number of analytical tools accurately studied and evaluated. To analyze the growth of the key players operating on the market, the analytical instruments such as Porter's five force analyses, the feasibility study and the investment return analysis were used.
Key Players & Strategies
Allergan Plc., Pfizer Inc., Sanofi, Ferring B.V., Flexion Therapeutics, Inc.., Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, and Chugai Pharmaceutical Co., Ltd. are major actors operating on the common pain injections market. Inc. Key players expand their product portfolio by combining, acquiring and cooperating with leading medical firms that are expected to improve the availability of the products and thus boost the market.